INSTRUCTIONS Polycystic ovary syndrome: An update
- Read the article. The test for this CE activity is to be taken online at www.nursingcenter.com/CE/nursing.
- You'll need to create (it's free!) and log in to your personal CE Planner account before taking online tests. Your planner will keep track of all your Lippincott Professional Development online CE activities for you.
- There's only one correct answer for each question. A passing score for this test is 13 correct answers. If you pass, you can print your certificate of earned contact hours and access the answer key. If you fail, you have the option of taking the test again at no additional cost.
- For questions, contact Lippincott Professional Development: 1-800-787-8985.
- Registration deadline is June 4, 2021.
Lippincott Professional Development will award 1.5 contact hours and 0.5 pharmacology credits for this continuing nursing education activity. Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.5 contact hours, and the District of Columbia, Georgia, and Florida CE Broker #50-1223.
Payment: The registration fee for this test is $17.95.
Polycystic ovary syndrome: An update
GENERAL PURPOSE: To present a comprehensive review of PCOS. LEARNING OBJECTIVES/OUTCOMES: After completing this continuing-education activity, you should be able to: 1. Outline the clinical presentation of PCOS. 2. Describe the diagnostic criteria for PCOS. 3. List the currently recommended interventions for patients with PCOS.
- Women who have PCOS have an increased incidence of which endocrine disorder?
- metabolic syndrome
- In patients who have PCOS, acne is often
- Hirsutism in patients with PCOS develops gradually and intensifies with
- weight gain.
- Compared with women who have mild hyperandrogenemia, those who have severe hyperandrogenemia are more likely to see hair loss at the
- A common chief complaint for women in primary care who require screening for PCOS is
- irregular menstrual cycles.
- recurrent constipation.
- persistent fatigue.
- Which characteristic of menstrual cycles is suggestive of anovulation?
- extreme pain
- heavy bleeding
- duration lasting more than 35 days
- If not diagnosed before menstruation ceases, menopausal women may only present with
- Which is not likely to be a differential diagnosis for patients who have PCOS?
- congenital adrenal hypoplasia
- insulin resistance
- Which guideline for diagnosing PCOS is recommended by the Endocrine Society?
- NIH Criteria
- Rotterdam Criteria
- Androgen Excess and PCOS Society criteria
- On pelvic or transvaginal ultrasound, patients who have PCOS have
- at least 30 follicles and an ovarian volume larger than 15 mL.
- more than 12 follicles and an ovarian volume smaller than 10 mL.
- more than 12 follicles and an ovarian volume larger than 10 mL.
- When diagnosing PCOS in adolescents younger than 17, clinicians should
- confirm infrequent menstrual periods.
- perform pelvic ultrasound.
- require a fertility evaluation.
- If PCOS is not diagnosed before menopause, clinicians should
- consider the need for oophorectomy.
- perform transvaginal ultrasound.
- not make this diagnosis.
- For women who choose not to take OCPs but require contraception, a recommended option for managing PCOS is an IUD in addition to
- Clinicians should not prescribe OCPs for patients who
- have a family history of colon cancer.
- are older than 35 and smoke.
- have a thyroid disorder.
- Which of the following treatments for hair removal is being used more frequently as a permanent means of managing hirsutism?
- Which of the following drugs is an androgen receptor blocker that has the potential to decrease excessive hair growth in women?
- Which of the following drugs requires that prescribers be registered with the iPLEDGE program?
- Which of the following is a contraindication for taking metformin?
- breast cancer
- deep-vein thrombosis
- severe kidney impairment